Tingyan Shi

机构：Sun Yat-sen University, Nantong University, Fudan University, Affiliated Hospital of Nantong University, Fudan University Shanghai Cancer Center, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-5356-0365

发表论文 61 篇 · 总被引 1493 次 · h-index 18

代表论文

• Promises and challenges of adoptive T-cell therapies for solid tumours (2021 · British Journal of Cancer · 被引 275)
• Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial (2024 · ESMO Open · 被引 36)
• Minimally invasive injection of biomimetic Nano@Microgel for in situ ovarian cancer treatment through enhanced photodynamic reactions and photothermal combined therapy (2023 · Materials Today Bio · 被引 35)
• Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial (2024 · Nature Medicine · 被引 28)
• Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer (2023 · Science Advances · 被引 26)
• Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation (2024 · Nature Communications · 被引 17)